Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Roger Perlmutter’s latest ‘retirement’ gig opens a door to the bustling China biotech scene
5 years ago
Bioregnum
China
CAR-M era begins as Carisma doses first patient
5 years ago
Cell/Gene Tx
Covid-19 roundup: Facing supply delay, UK fires shot at Europe after EU threatens to ban AstraZeneca vaccine exports
5 years ago
Coronavirus
Are radiopharmaceuticals ready for the mainstream? Novartis, Bristol Myers Squibb bet yes on MPM's platform take
5 years ago
Financing
Got a revolutionary healthcare company? Bob Nelsen, Jeff Leiden’s SPAC has $500M to take it public
5 years ago
Financing
Little Apellis is arming itself for a David and Goliath battle over a blockbuster drug franchise
5 years ago
R&D
Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says
5 years ago
FDA+
Coronavirus
Lack of early efficacy for Translate Bio's mRNA-based cystic fibrosis drug raises some big questions
5 years ago
R&D
Denied top job, Mike Nally exits chief marketing job at Merck as the big C-suite shakeup continues
5 years ago
People
New Purdue bankruptcy plan roundly criticized as Sacklers offer $4B+; Sana seals pact with Fujifilm for iPSC-derived ...
5 years ago
News Briefing
Dean Li invites another under-the-radar biotech to Merck's dealmaking table as Amathus signs neurodegeneration pact
5 years ago
Deals
Europe mulls halting Covid-19 vaccine exports to some countries
5 years ago
Pharma
FDA+
A departing CMO pens a sad farewell as he heads back to the UK biopharma scene
5 years ago
People
Bioregnum
Court win for Eli Lilly halts HHS’s drug discount rule
5 years ago
Pharma
FDA+
Hunting unicorn status, the co-inventors of the Oxford-AstraZeneca vaccine raise a monster B round
5 years ago
Financing
After a roller coaster ride, Sage COO strikes out on his own to chart a new biotech path
5 years ago
People
Covid-19 roundup: Alnylam, Vir quietly deprioritize Covid-19 drug; Data suggest AstraZeneca's vaccine is only 10.4% ...
5 years ago
Coronavirus
Another bluebird exec jumps ship as questions swirl over gene therapies and imminent split
5 years ago
People
Cell/Gene Tx
Montreal AI startup with a touted advisor licenses its 'few-shot' platform to Repare for synthetic lethality ...
5 years ago
Deals
Discovery
Eli Lilly, Novartis back a biotech startup boasting 'best of both worlds' protein degraders
5 years ago
Financing
Fresh out of the bluebird bio oncology split, Joanne Smith-Farrell flies the coop to Be Bio and its B cell platform
5 years ago
People
Cell/Gene Tx
FTC pledges to aggressively crack down on pharma mergers
5 years ago
Pharma
FDA+
Roche builds long-term case for Evrysdi with 2-year SMA data; ExeVir nets $50M Series A for llama-derived Covid ...
5 years ago
News Briefing
Covid-19 roundup: As AstraZeneca deals with vaccine woes, US turns attention to its antibody treatment; Moderna doses ...
5 years ago
Coronavirus
First page
Previous page
735
736
737
738
739
740
741
Next page
Last page